Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report

MLA

R. Silva, et al. “Investigating a Clinically Actionable BRAF Mutation for Monitoring Low-Grade Serous Ovarian Cancer: A Case Report.” Case Reports in Women’s Health, vol. 34, no. e00395-, Apr. 2022. EBSCOhost, https://doi.org/10.1016/j.crwh.2022.e00395.

APA

R. Silva, B. Moran, S. Das, N. Mulligan, M. Doughty, A. Treacy, K. Sheahan, C.M. Kelly, A.G. Duffy, A.S. Perry, & D.J. Brennan. (2022). Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report. Case Reports in Women’s Health, 34(e00395-). https://doi.org/10.1016/j.crwh.2022.e00395

Chicago

R. Silva, B. Moran, S. Das, N. Mulligan, M. Doughty, A. Treacy, K. Sheahan, et al. 2022. “Investigating a Clinically Actionable BRAF Mutation for Monitoring Low-Grade Serous Ovarian Cancer: A Case Report.” Case Reports in Women’s Health 34 (e00395-). doi:10.1016/j.crwh.2022.e00395.